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A B S T R A C T   
Non-ribosomal peptides are a group of structurally diverse natural products with various important therapeutic 
and agrochemical applications. Bacterial pyrrolizidine alkaloids (PAs), containing a scaffold of two fused five- 
membered ring system with a nitrogen atom at the bridgehead, have been found to originate from a multido-
main non-ribosomal peptide synthetase to generate indolizidine intermediates, followed by multistep oxidation, 
catalysed by single Bayer-Villiger (BV) enzymes, to yield PA scaffolds. Although bacterial PAs are rare in natural 
product inventory, bioinformatics analysis suggested that the biosynthetic gene clusters (BGCs) that are likely to 
be responsible for the production of PA-like metabolites are widely distributed in bacterial genomes. However, 
most of the strains containing PA-like BGCs are not deposited in the public domain, therefore preventing further 
assessment of the chemical spaces of this group of bioactive metabolites. Here, we report a genomic scanning 
strategy to assess the potential of PA metabolites production in our culture collection without prior knowledge of 
genome information. Among the strains tested, we found fifteen contain the key BV enzymes that are likely to be 
involved in the last step of PA ring formation. Subsequently one-strain-many-compound (OSMAC) method, 
supported by a combination of HR-MS, NMR, SMART 2.0 technology, and GNPS analysis, allowed identification 
and characterization of a new [5 + 7] heterobicyclic carbamate, legoncarbamate, together with five known PAs, 
bohemamine derivatives, from Streptomyces sp. CT37, a Ghanaian soil isolate. The absolute stereochemistry of 
legoncarbamate was determined by comparison of measured and calculated ECD spectra. Legoncarbamate dis-
plays antibacterial activity against E. coli ATCC 25922 with an MIC value of 3.1 μg/mL. Finally, a biosynthetic 
model of legoncarbamate and other bohemamines was proposed based on the knowledge we have gained so far.   
1. Introduction 
Pyrrolizidines are a group of organic compounds that possess a fused 
bicyclic five-membered rings with a nitrogen atom at the bridgehead 
position. While pyrrolizidine alkaloids (PAs) have been mainly found as 
plant metabolites, some of which are part of plant defence mechanism 
against insect herbivores, less than 30 PAs have been discovered from 
bacterial origins [1]. The representatives include clazamycins 1 [2], 
bohemamine 2 [3], jenamides A1/A2 4 [4], and more recently legon-
mycins 3 [5], pyrrolizixenamide 5 [6], bohemamine dimer C 6 [7], and 
azetidomonamide (azabicyclene) 7 [8,9] (Fig. 1A). Bacterial PAs exhibit 
a broad range of bioactivities and as such they have attracted consid-
erable interest from both academic research groups and the pharma-
ceutical industry [11]. 
Recently we disclosed the biosynthetic origin of two bacterial PA 
specialised metabolites (SMs), denoted as legonmycins A and B [4], 
isolated from a talented Ghanaian isolate, Streptomyces sp. MA37 [4, 
10–16]. We have demonstrated that legonmycins are biosynthesized 
from an NRPS assembly line to generate the key intermediates, lego-
nindolizidines 8 ([5 + 6] heterobicyclic ring system). The 
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monooxygenase LgnC acts on 8 and catalyses a multistep Baeyer-Villiger 
process of ring expansion to afford carbamates, 9 ([5 + 7] heterobicyclic 
ring system). Subsequent ring-opening by hydrolysis and 
decarboxylation-driven ring contraction finally provides the [5 + 5] 
heterobicyclic pyrrolizidine ring (Fig. 1B) [4]. 
The biosynthetic gene clusters (BGCs) that are likely to be respon-
sible for PA productions have been shown to be widely spread in bac-
terial genomes, suggesting that PA SMs may have important biological 
functions [6]. One of the key features among these BGCs is that they all 
encode LgnC-like monooxygenase open reading frames (ORFs) that are 
likely to be responsible for the biotransformation from [5 + 6] indoli-
zidine intermediates to [5 + 5] PA scaffolds. Bioinformatics analysis of 
these putative BGCs indicated that the biosynthetic genes encoding 
tailoring catalytic functions appear to be diverse [6]. In contrast to the 
biodiversity of BGCs, the chemical space of this group of bacterial PA 
SMs has not been fully assessed. Many of these bacterial strains are not 
deposited in the public domain. Thus, it is difficult to assess whether 
these strains are able to produce PA-like metabolites with chemical di-
versity under laboratory conditions. Considering that LgnC-type mon-
ooxygenases are the key enzymes to biosynthesize PA metabolites, we 
reasoned that it was possible to apply the PCR-based genomic scanning 
strategy of using the sequences that are conserved among LgnC-type 
monooxygenases as probes to identify strains in either public or our 
own culture collections that may contain PA BGCs, followed by facili-
tating one strain many compounds (OSMAC) method [17] to isolate new 
PA metabolites for biological assessments. 
Here we report the application of PCR-based genomic scanning of 58 
actinomycete strains from NCIMB, the largest bacterial culture collec-
tion in the UK and our own culture collection. This resulted in the 
identification of 15 potential PA producing strains. Among these strains, 
one of our own cultures, the Ghanaian isolate Streptomyces sp. CT37 
(CT37) was found to produce PA-like metabolites. Subsequent chemical 
workup and structural elucidation allowed the identification of an un-
usual [5 + 7] heterobicyclic carbamate alkaloid, legoncarbamate 10, 
and a known PA metabolite, NP25302 11. NOE analysis together with 
electronic circular dichroism (ECD) measurement and computational 
calculation confirmed that 10 has (5S, 8S) configuration. Further anal-
ysis of the semi-purified extracts from the culture of CT37 using LC-MS- 
based Global Natural Products Social molecular networking (GNPS) 
[18], in conjunction with newly developed NMR-based machine 
learning tool “Small Molecule Accurate Recognition Technology” 
(SMART 2.0) [19] allowed identification of the presence of four known 
bohemamine SMs 15–18. In silico analysis of the annotated genome of 
CT37 together with current knowledge of PA biosynthesis allowed 
identification of the BGC of the carbamate alkaloid 10 and other 
PA-related SMs 15–18. 
2. Results and discussion 
With recently discovered PA metabolites and their corresponding 
BGCs, we compared the biosynthetic enzymes encoded in these BGCs 
with key legonmycin biosynthetic enzymes. It appears that this group of 
Fig. 1. A. Representatives of bacterial pyrrolizidine alkaloids. B. A proposed biosynthetic model of legonmycins.  
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SMs are assembled by multidomain non-ribosomal peptide synthetases 
(NRPSs) to generate indolizidine intermediates, followed by essential 
LgnC-like monooxygenases to provide PA bicyclic frameworks. LgnC- 
like monooxygenases catalyse unusual multistep chemical trans-
formation from indolizidine via carbamate to pyrrolizidine [4] which is 
clearly different from other Bayer-Villiger (BV) enzymes [20]. There-
fore, it is possible to apply degenerate primers, according to the 
conserved amino acids sequences of these monooxygenases, to scan 
genomic DNAs of a large amount of available bacterial collections in 
order to identify potential PA producing strains. To this end, we adopted 
a bioinformatics-based approach to break the trend in these BV mono-
oxygenases (Fig. S1A). Having compiled data from reported putative BV 
monooxygenase enzymes together with other types of BV mono-
oxygenases, protein motif elicitor (MEME) [21] analysis enabled us to 
identify three highly conserved motifs: GxGxxG, YWWxTKN, and 
GDAAH (where ‘x’ is any amino acid and each independently represents 
the number of x between each conserved residue) (Fig. S1A). GxGxxxG 
motif has hitherto been used to indicate the presence of FAD which 
could as readily indicate flavin-monooxygenase-related enzymes [22]. 
However, YWWxTKN, and GDAAH motifs, covering approximate 80 
amino acid residues, are unique among LgnC-like monooxygenases and 
as such these two motifs may be used as PCR probe to screen LgnC-like 
monooxygenase from uncurated genomic DNAs of available bacterial 
strains (Table S1). 
To examine the feasibility of PCR-based genomic scanning approach, 
we first amplified the internal fragment of lgnC with our designed 
degenerate primers using the genomic DNA of Streptomyces sp. MA37 as 
the positive control and Streptomyces albus as a negative control. The 
expected PCR product with approximately 240 bp, were observed in 
DNA electrophoresis analysis (Fig. S1B) in the positive control but not in 
the negative control. The DNA sequence of the PCR product was further 
confirmed to be the targeted internal DNA fragment of lgnC by DNA 
sequencing. 
In the collaborative natural product discovery programme with 
NCIMB Ltd, we obtained 56 Streptomyces strains (Table S2). We extract 
the genomic DNAs from these strains together with soil isolates in our 
laboratory including the new indole alkaloid SM producer, Streptomyces 
sp. CT37 (CT37) [23], and performed PCR scanning using these DNAs as 
templates. Among these strains, we were able to identify fifteen positive 
PCR results with the expected DNA length. These DNAs were then 
cloned into a commercially available plasmid via TA cloning method 
(Method and experiments). The constructs were extracted from the 
positive clones which was subjected for DNA sequencing. Finally, the 
resulting DNA sequences were annotated using FramePlot to predict 
protein-coding regions. The amino acid alignment with the one in LgnC 
as a control and phylogenetic analysis indicated that these amplified 
DNAs are indeed encoded the fragments (~80 amino acid (AA) residues) 
of LgnC-like monooxygenases with high AA similarity (80%–95%), 
suggesting that these strains potentially possess these BV mono-
oxygenases (Fig. S2). 
In order to examine whether these strains can produce PA-like me-
tabolites under laboratory conditions, we applied the OSMAC approach 
to activate the cryptic PA-like BGCs among these strains. Eight standard 
Streptomyces media (ISP2, Modified Bernett’s, ISP3, ISP4, ISP5, ISP6, 
ISP7, Starch Casein) available in our laboratory were used (Table S3). 
After small scale fermentation (50 mL, 7 days, 28 ◦C), one hundred 
twenty of these culture broths were extracted using ethyl acetate to 
generate crude extracts, followed by LC-HRESIMS analysis. Targeted 
metabolomics using GNPS network analysis were then applied to 
construct extensive metabolite networks of these extracts. Detailed 
analysis of these networks enabled the identification of a small node 
network from an extract of CT37 that is likely to contain PA-like me-
tabolites (Fig. S3). With this information on hands, we carried out a 
large fermentation (8 L) of CT37 in MB medium (7 days, 28 ◦C). To 
absorb small molecule components, Diaion®HP-20 (3 g/50 mL, Mitsu-
bishi Chemical Co., Binasco, Italy) was added. After filtration, resins 
were extracted extensively with methanol to generate crude extracts, 
followed by vacuum liquid chromatography to provide ten fractions. 
Fractions containing PA-like metabolites were combined and subjected 
to semipreparative HPLC separation to yield a new compound, 10 (1.0 
mg), together with one known bohemamine metabolite, NP25302 11 
(1.5 mg) [3], and two semi-purified fractions, each of which is likely to 
contain a mixture of two analogue compounds that were proved difficult 
to be separated. 
10 was obtained as a white powder with a molecular formula of 
C15H20N2O4+ deduced by high-resolution electrospray ionization mass 
spectrometry (HRESIMS) (observed m/z [M+H]+ = 293.1502, calcu-
lated [M+H]+ = 293.1496; Δ = 2.047 ppm) with 7◦ of unsaturation 
(Figs. S4–5). The planar structure of 10 was characterized using spec-
trometric and spectroscopic analyses including HRESIMS, 1D and 2D 
nuclear magnetic resonance spectroscopy (NMR) (Fig. 2, Table S4, 
Figs. S4–9). The 1H NMR spectrum of 10 exhibited three methine proton 
signals (δH 6.65, 5.86, 4.17), two pairs of methylene groups (δH 2.69 and 
1.88, 2.14 and 1.54), four methyl group singlets (δH 2.19, 1.93, 1.51 and 
1.18), and an exchangeable proton (δH 7.28) was observed in DMSO‑d6. 
The 13C NMR spectrum exhibited fifteen carbon signals, including three 
carbonyl carbon signals (δC 196.7, 164.8, 159.0) and three quaternary 
carbon signals that appeared downfield from 70 ppm (δC 155.5, 152.9, 
and 71.4). 
The interpretation of the 2D NMR spectral data allowed for the 
construction of two structural fragments. One fragment, isobutene 
motif, was established by interpreting the HMBC correlations from H-4’ 
(δH 1.93) to C-5’ (δC 19.1), C-2’ (δC 118.5), and C-1’ (δC 164.8), and H-2’ 
(δH 5.86) to C-4’ (δC 26.2) and C-5’ (δC 19.1) as well as the NOE corre-
lation of H-2′ to H-4’ (Fig. S10). The other fragment was assigned to be 
tetrahydropyrrolo [1,2-c][1,3]oxazepine-1,5-dione. The 1H–1H COSY 
correlations corresponding to the connectivity of four carbons from C- 
5M to C-7 as well as the HMBC correlation of H-5 (δH 4.17) and C-8 (δC 
71.4) allowed for the construction of the five-membered ring system. 
The HMBC correlations between H-5 to C-4 (δC 159.0) and H-8M (δH 
1.51) and C-1 (δC 196.7) provided valuable information for the seven- 
membered ring moiety. Interpretation of the HMBC analysis allowed 
to identify correlations from H-2 (δH 6.65) and NH (δH 7.28) to C-3 (δC 
152.9), NH(δH 7.28) to C-2’ (δC 118.5) and C-1 (δC 196.7), H-2 to C-1’ (δC 
164.8) and C-3 (δC 152.9), indicating that the isobutene motif is posi-
tioned at C-3 of the oxazinone ring through the amide motif (Fig. S8b). 
In order to identify the relative configuration between the two 
methyl groups on C-5 and C-8, NOESY data was collected in which 
signals, albeit weak, showed a correlation between H-5 and H-8M (δH 
1.51) (Fig. S11). This NOE correlation allowed us to assign the relative 
geometric relationship of H-5 and the methyl group at C-8 as a cis 
configuration. We utilized the empirical ECD to determine the absolute 
configuration of 10. A comparison of the measured ECD curve with the 
predicted ECD spectra showed that the measured ECD of 10 matches 
with the calculated ECD curve of (5S,8S)-10 (Fig. 3). Search in the 
natural product database, such as Antibase [27], only resulted in two 
analogues of 10 that contains the [5 + 7] heterocyclic carbamate ring 
system, which are cyclocarbamides, 12a and 12b, isolated from an un-
identified Steptoverticillium sp [28]. and SB-315021 13 from Pseudo-
monas fluorescens DSM 11579 [29] (Fig. 2). 
Compound 11 was isolated as a yellow powder. Its molecular for-
mula was determined to be C14H20N2O2 based on the HRESIMS data. 
The UV spectrum showed similar absorption to legonmycins at 250, 282 
and 334 nm [3]. A comparison of its NMR spectra with those of known 
bohemamine analogues indicated that the 1H,13C and 2D NMR data of 
11 were identical to NP25302 [3] (Figs. S12–15, Table S5). 
Taken together, compound 10 is a new carbamate-containing [5 + 7] 
heterobicyclic alkaloid metabolite, which we named legoncarbamate, 
after its association with Legon, Ghana, the location of the University of 
Ghana. Compound 10 showed antibacterial activity against E. coli ATCC 
25922 with a minimum inhibitory concentration (MIC) value of 3.1 μg/ 
mL (Fig. S21). 
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Although various LC-MS-based dereplication tools, such as Global 
Natural Product Social molecular networking (GNPS) [18], have facili-
tated the targeted isolation of new SMs as well as rapidly dereplicating 
known ones, unambiguous identification of SMs still requires isolation 
and structure characterization. Recently, a new NMR-based machine 
learning tool, Small Molecule Accurate Recognition Technology 
(SMART 2.0) [26], has been developed for mixture analysis and subse-
quent discovery and characterization of SMs from environmental iso-
lates. In our case, the minute amount of two semi-purified fractions from 
the culture of CT37 prevented further purification to obtain the pure 
substances for structural elucidation. Therefore, we applied this newly 
developed cheminformatic tool to assign the structures of the SMs pre-
sent in these two fractions. Subsequently, the HSQC spectra of these two 
fractions were submitted to SMART NMR. SMART annotation combined 
with GNPS analysis and NMR interpretation suggested that the majority 
of the compounds in one fraction are two known bohemamine de-
rivatives, bohemamine B 15 [24] and 5-chlorobohemamine C 16 [24] 
while bohemamine 17 [30] and bohemamine F 18 [25] in the other 
fraction (Figs. S16–S20, Tables S6–S7). 
The [5 + 7] heterobicyclic SMs containing a carbamate moiety are 
rare in the natural product inventory. Cyclocarbamide 12 [28] and 
SB315021 13 [29] are the only two examples containing such a scaffold 
Fig. 2. Structures of legoncarbamate 10 and 
NP25302 11 together with two known metabolites 
that contain [5 + 7] carbamate ring systems, cyclo-
carbamide 12, SB315021 13 and the metabolite bra-
bantamide A 14. Compound 10 with key correlation 
spectroscopy (COSY) (− ), key heteronuclear multiple 
bond correlation (HMBC) (→) and NOE (→) correla-
tions. The structures of compounds 15–18 [3,24,25] 
in the bracket were deduced from the analyses of 
NMR-based artificial intelligence SMART 2.0 tech-
nology [26] in conjunction with LC-MS-based GNPS 
[18] and genomic context.   
Fig. 3. A. Measured and calculated ECD spectra for 10. B. Two possible structures of 10 that contain cis-configuration between the methyl group at C8 and the 
hydrogen at C5. 
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discovered thus far. It is worth to note that 13 was proposed to be the 
biosynthetic intermediate of brabantamide A 14, an antibacterial SM 
isolated from plant-associated Pseudomonas strains [31,32]. Although 
brabantamide A 14 is a bicyclic pyrroloxazole SM, which is structurally 
different to all of PA SMs, its biosynthetic gene cluster is remarkably 
similar to the ones of PAs. One of the key differences between bra-
bantamide A and PA SMs lies on the putative monooxygenase BraC 
which was proposed to catalyse a BV oxidative ring expansion to yield 
13 as the biosynthetic intermediate, the co-occurring metabolite in the 
producing strains, followed by the ring re-arrangement via allylic 1, 
3-transposition [31]. It has yet remained to be determined whether 12 
is originated from PA-like pathways or the 14-like pathway. The pro-
posed biotransformation catalysed by LgnC-like monooxygenases and 
the structural relationship among 10, 12 and other co-occurring 
bohemamines suggested that they are likely to originate from the 
same PA biosynthetic pathway. Inspection of the structures of 10 and 12 
led to the speculation that the precursors of the core of both compounds 
are (S)-5-methyl-proline and dehydroalanine, a dehydrated form of 
serine, a similar model to the one proposed in the recent report of 
bohemamines isolated from the environmental isolate, Streptomyces sp. 
CB02009 [33]. (S)-5-methyl-proline is a rare occurring motif in natural 
products and is mainly found in actinomycin complexes [34] and anti-
biotic agent A-54556H [35]. The bio-origin of this motif remains to be 
disclosed. In silico analysis of CT37 annotated draft genome led to the 
identification of a putative gene cluster (lga), spanning approximately 
17.6 kbp. The centre of this cluster encodes one multidomain NRPS 
(LgaD, Fig. 4A). LgaD possesses a canonical arrangement of 
C1-A1-T1-C2-A2-T2-TE domains (Fig. 4A). The A domains of LgaD were 
predicted to activate serine and proline/5-methylproline, the same as 
the one in bohemamines [33], respectively. The gene product, LgaE, 
sharing high AA sequence identity (93%) with LgnC-like mono-
oxygenases, is likely to catalyse the key biotransformation from indoli-
zidine intermediate 18 to pyrrolizidine 20 via bicyclic carbamate 
intermediate 19 (Fig. 4B). Unlike the legonmycin pathway, the lga BGC 
contains a series of tailoring enzymes. For example, the gene product 
LgaA is likely to catalyse the methylation at C-7 position in bohemamine 
SMs. It is likely that a promiscuous methylation enzyme methylates the 
key intermediate, carbamate 19, at C8 position during the catalytic cycle 
of LgaE, to generate legoncarbamate 10. It remains to be elusive 
whether LgaA is responsible for the methylation at C8 position of 10. 
The genes, lgaF and lgaG, encode branched-chain α-ketoacid dehydro-
genase and isovaleryl CoA dehydrogenase, respectively, which are likely 
involved in catalysing the oxidative decarboxylation of 4-methyl-2-oxo-
pentanoic acid to yield isovaleryl CoA and transfer isovaleryl CoA to 
3-methyl pentenyl CoA (Fig. 4B, Table S8). 
3. Material and method 
3.1. General experimental procedures 
The optical rotation was recorded using ADP 410 polarimeter (Bel-
lingham + Stanley Ltd.2007, Kent, UK) equipped with a light emitting 
diode and interference filter. UV spectra were recorded on an Accela 
PDA detector (Waldbronn, Germany). IR spectra were obtained on a 
Fourier transform infrared (FTIR) spectrometer (2013, PerkinElmer, UK) 
equipped with an Attenuated Total Reflection (ATR, PerkinElmer, 
Buckinghamshire, UK) diamond cell for sample loading was used for 
infrared spectroscopy experiments. 1D and 2D NMR spectra were 
Fig. 4. A. the organisation of the putative lgc BGC in Streptomyces sp. CT37. B. A proposed model of legoncarbamate 10 and bohemamine derivatives, 15–18, 
identified in CT37. 
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acquired on a Bruker AVANCE IIIHD400MHz (AscendTM14.1 T, UK) 
with Prodigy TCITM cryoprobe at 298 K in CD3OD and DMSO‑d6 (Goss 
Scientific, Massachusetts, MA, USA). Trimethylsilane (TMS) was used as 
an internal standard. HRESIMS data were obtained in positive ESI mode 
with a mass range of 100–2000 m/z (maximum resolution 30,000) on a 
Thermo Scientific MS system (LTQ XL/LTQ Orbitrap Discovery, Wald-
bronn, Germany). Reserpine (m/z 609.2807) was used as a lock mass for 
internal calibrant during data acquisition. The following instrument 
parameters were used: capillary voltage 45 V, spray voltage 4.5 kV, 
capillary temperature 200 ◦C, auxiliary gas flow rate 10–20 arbitrary 
units, and sheath gas flow rate 5 arbitrary units; furthermore, an auto-
mated full dependent MS-MS scan was applied. The injected samples 
were chromatographically separated in Thermo Instrument HPLC sys-
tem (Accela PDA detector, Waldbronn, Germany), Accela PDA auto-
sampler and Accela Pump (Agilent Technologies, Waldbronn, Germany) 
using a C18 (Sunfire 150 × 46 mm) column. The gradient elution for 
separation was CH3CN/H2O with 0.1% trifluoroacetic acid (TFA) (from 
0% to 100% for 30 min, flow rate, 1.0 mL/min, UV detection max 340 
nm). 
3.2. Strain collection 
Fifty-eight strains were used for genome scanning which was listed in 
Table S2. Among which 56 were provided by NCIMB while the 
remaining two were isolated from soil samples collected in Ghana as 
described in previous papers [23,36]. 
3.3. Cultivation and genomic DNA extraction 
Strains were cultured in 50 mL ISP2 media and harvested after 7 
days. Genomic DNA was extract using the following protocol to generate 
a library of genomic DNA. The genomic DNA in this study was extracted 
from 10 mL cell culture. Cell pellet was harvested by centrifugation and 
resuspended in 500 μL SET buffer. The cell suspension was mixed with 
lysozyme (4 mg/mL, final concentration) and incubated at 37 ◦C for 30 
min. SDS (60 μL, 10% (w/v)) and NaCl (200 μL, 5 M) were then added to 
the mixture, followed by another incubation at 60 ◦C for 30 min. The 
protein was precipitated with the mixture of phenol, chloroform and 
isoamylol (500 μL, ratio of 25:24:1), and the resultant solution was 
mixed by vortex. The supernatant was separated by centrifuge and 
transferred to a new Eppendorf tube with isopropanol for DNA precip-
itation (0.8 vol). The precipitated DNA was washed with 75% (v/v) 
ethanol, followed by the second wash of 100% ethanol. DNA pellet was 
dried at room temperature and dissolved in sterile Milli-Q water (200 
μL). 
3.4. Genome scanning of strain library 
MEME (Multiple EM for Motif Elicitation) was used for protein motif 
and degenerate primers design (Table S1) [37]. The DNA fragments 
were amplified from Streptomyces genomic DNA in the library using Taq 
DNA polymerase (Invitrogen, UK) with the degenerated primers. 
The homologues genes of lgnC amplified from Streptomyces genomic 
DNA templates were inserted into pCR™ plasmid using TA Cloning™ Kit 
(Invitrogen, UK). The constructed plasmid was sequenced by the Dundee 
sequencing service. 
3.5. Cultivation conditions 
OSMAC strategy was applied [17] using 8 different fermentation 
broths (ISP2-ISP7, Modified Bennett’s, Starch Casein, Table S1). These 
were selected based on the recommended medium for Streptomyces 
species, which differ with respect to carbon source and salt concentra-
tion [38]. 
The small scale culture (50 mL) of CT37 strain was prepared by 
inoculating a single colony of the bacteria in a solid medium of choice 
and incubated at 28 ◦C, 180 rpm for 7 days (Incu-shake FL16-2, SciQuip, 
Shrewsbury, UK). Subsequently, Diaion®HP-20 (3 g/50 mL, Mitsubishi 
Chemical Co., Binasco, Italy) was added to the fermentation cultures 
under sterile conditions. The flasks were left at the same shaking tem-
perature and conditions for 18 h. 
The culture broths were filtered under vacuum (Buchi pump V100, 
Buchi, Manchester, UK), and the HP-20 resin was rinsed with Milli-Q 
water and extracted exhaustively with methanol (MeOH, Fisher Chem-
ical HPLC grade). All the methanol extracts were combined, and 
concentrated under reduced pressure (Buchi Rotavapor R200, Buchi, 
Manchester), and subjected to high-resolution electrospray ionization 
Liquid chromatography mass spectrometry analysis. 
3.6. Large scale fermentation 
For scale-up fermentation, a seed culture (50 mL) of CT37 was pre-
pared following the same inoculation procedure as small scale cultiva-
tion. On the 3rd day, the seed culture was inoculated (1:100) into a 2 L 
Corning™ polycarbonate baffled flask (contains 250 mL broth). Each of 
the flasks (8 L in total) were plugged with Fisherbrand™ polyurethane 
foam stoppers (Fisher Scientific, UK). The cultures were fermented for 7 
days under the same condition as described for the small scale 
fermentation. 
3.7. HPLC-HRMS/MS analysis and metabolites annotation using GNPS 
and SMART 2.0 
The MS/MS data were converted from. RAW to. mzXML files using 
the ProteoWizard MSconvert software [39]. A molecular network was 
generated using Feature-Based Molecular Networking (FBMN) workflow 
[40] on Global Natural Product Social networking (GNPS) [18] (https 
://gnps.ucsd.edu). The mass spectrometry data were pre-processed 
with MZmine v2.38 [41] and exported to GNPS for FBMN analysis. 
The data were filtered to remove all MS/MS fragment ions within ±17 
Da of the precursor m/z. MS/MS spectra were window filtered by 
choosing only the top 6 fragment ions in the ±50 Da window throughout 
the spectrum. The precursor ion mass tolerance was set to 0.02 Da with 
an MS/MS fragment ion tolerance of 0.02 Da to create consensus 
spectra. The consensus spectra that contained fewer than four spectra 
were discarded. The edges were filtered to ensure a cosine score above 
0.65 and more than four matched peaks. The edges between two nodes 
were kept in the network if each of the nodes appeared in each other’s 
respective top 15 most similar nodes. The spectra in the network were 
then searched against GNPS spectral libraries [18] and annotated by the 
DEREPLICATOR [42]. The library spectra were filtered in the same 
manner as the input data, where a score above 0.65 and at least 4 
matched peaks are required. The created molecular network was visu-
alized using Cytoscape software v3.4.0 (Seattle, WA, US) [43]. 
Smart 2.0 was used for rapid structure prediction of major constit-
uents from crude extracts and fractions (https://smart.ucsd.edu/cla 
ssic). The experimental HSQC data was annotated to generate a digita-
lized HSQC spectrum for library alignment and analysis. Top 6 struc-
tures were listed based on cosine similarity score [19]. 
3.8. HPLC isolation 
The compounds of interest were identified in S2 fraction, hence 
further fractionation was carried out in this fraction using High Pressure 
Liquid Chromatography (HPLC, Agilent Technologies 1260 infinity, 
Waldbronn, Germany). The purification was performed using a linear 
gradient from 10% H2O:MeOH (95:5) to 100% MeOH for 30 min with a 
solvent flow rate of 1.5 mL/min (C-18 ACE 10 μM 10 × 250 mm col-
umn). As a result, 10 (1.0 mg), 11 (1.5 mg) were isolated. 
Legoncarbamate (10): white powder, [α]25D +11.3 (c 0.50, MeOH); UV 
(MeOH) λmax (log ε) 275 nm; ECD (c = 1.0 mg/mL, MeOH) λmax (Δε) 338 
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(+13), 284(-30), 248(+10), 215(-5) nm; IR νmax 3404,1742, 1728, 
1671, 1615 cm− 1; 1H and 13C NMR, Table S4; HRESIMS m/z 293.1502 
[M + H]+. 
NP25302 (11): yellow powder, [α]25D +9.2 (c 0.50, MeOH); UV 
(MeOH) λmax (log ε) 250, 282, 334 nm; ECD (c = 1.0 mg/mL, MeOH) 
λmax (Δε) 338(+12), 284(-25), 248(+6), 212(-4) nm; IR νmax 3283, 
3180, 1711, 1642, 1571 and 1497 cm− 1; 1H and 13C NMR, Table S5; 
HRESIMS m/z 249.1603 [M + H]+. 
3.9. Antibacterial assay 
Minimum inhibitory concentrations (MIC) were determined 
following the antibacterial assay protocols described in accordance with 
standards recommended by the National Committee for Clinical Labo-
ratory Standards (NCCLS) [44]. 
A panel of pathogens was tested against including Escherichia coli 
(ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Streptococcus B 
(ATCC 12386), Staphylococcus aureus ATCC 25923, Staphylococcus hae-
molyticus clinical isolate 8-7A, Staphylococcus epidermidis ATCC 35984 
and Enterococcus faecalis ATCC 29212. All bacteria were cultured in 
Mueller–Hinton broth. The assays were performed in serial dilutions (in 
triplicates) in 96-well plates (Nunc, Thermo Fisher Scientific, UK), 
wherein a 50 μL suspension (log phase) of bacteria was incubated 
overnight at 37 ◦C and then supplemented with 50 μL of the test com-
pound or fraction. The positive control consisted of the bacteria plus 
Milli-Q water (no test compound), while the negative control comprised 
the growth media and Milli-Q water. The absorbance was recorded after 
24 h (OD600) in a SpectraMax ABS Plus (Molecular Device) plate reader. 
The MIC was defined as the lowest concentration of a drug that inhibited 
visible bacterial growth. 
3.10. Measured and calculated electronic circular dichroism (ECD) 
ECD spectra were measured on a Jasco J810 Spectropolorimeter. Cell 
path length 0.05 cm. Data pitch 0.2 nm, Scanning range 400-200 nm at a 
rate of 20 nm/min with response 1.0 s, bandwidth 1 and three 
accumulations. 
In general, conformational analyses were carried out via random 
searching in the Sybyl-X 2.0 using the MMFF94S force field with an 
energy cutoff of 2.5 kcal/mol (Sybyl Software, version X 2.0; Tripos 
Associates Inc.: St. Louis, MO, 2013). The results showed eight lowest 
energy conformers for the compound. Subsequently, the conformers 
were re-optimized using DFT at the PBE0-D3(BJ)/def2-SVP level in 
MeOH using the polarizable conductor calculation model (SMD) by the 
GAUSSIAN 09 program (Gaussian, Inc., Wallingford CT, 2009). The 
energies, oscillator strengths, and rotational strengths (velocity) of the 
first 30 electronic excitations were calculated using the TDDFT meth-
odology at the CAM-B3LYP-D3(BJ)/def2-TZVP level in MeOH. The ECD 
spectra were simulated by the overlapping Gaussian function (half the 
bandwidth at 1/e peak height, sigma = 0.30 for all) [45]. To get the final 
spectra, the simulated spectra of the conformers were averaged ac-
cording to the Boltzmann distribution theory and their relative Gibbs 
free energy (ΔG). By comparing the experiment spectra with the 
calculated model molecules, the absolute configuration of the chiral 
centres was determined to be 5S, 8S. 
4. Conclusion 
In conclusion, we applied genomic scanning strategy to probe our 
culture collection to identify the potential producers of pyrrolizidine 
alkaloids (PAs). Fifteen out of fifty-eight strains tested have the capacity 
of producing PAs. One of these thirteen potential producers was found to 
produce known bohemamine derivatives and a new [5 + 7] hetero-
bicyclic alkaloid, legoncarbamate 10, using a combination of chemical 
workup, NMR-based structural elucidation, SMART 2.0 technology in 
conjunction with LC-MS-based GNPS analysis. The absolute stereo-
chemistry of legoncarbamate 10 was determined by a comparison of 
measured and calculated ECD spectra. Legoncarbamate 10 displays 
antibacterial activity against Gram-negative E. coli ATCC 25922 with an 
MIC value of 3.1 μg/mL. Finally, a biosynthetic model of legoncarba-
mate and other known bohemamine derivatives was proposed based on 
bioinformation analysis and current knowledge of PA biosynthesis. 
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